Abiopharma

🔍 Baroldi Joseph (Executive)

Company: IONIS PHARMACEUTICALS INC (IONS)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 19,350 shares of Non-Qualified Stock Option (right to buy) at $79.67 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-01 | Exercise: 2027-01-02 | equity_swap_involved: 0 | shares_owned_after: 19,350.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 2,600 shares of Non-Qualified Stock Option (right to buy) at $79.67 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-01 | Exercise: 2027-01-02 | equity_swap_involved: 0 | shares_owned_after: 2,600.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Grant on 01/02/2026 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2026. 25% of the shares subject to the option will vest and become exercisable on 01/02/2027. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.
• F2: Grant on 01/02/2026 to reporting person's spouse of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2026. 25% of the shares subject to the option will vest and become exercisable on 01/02/2027. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.